SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-19-015318
Filing Date
2019-03-15
Accepted
2019-03-15 17:08:07
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 a19-6607_1s3.htm S-3 426529
2 EX-4.6 a19-6607_1ex4d6.htm EX-4.6 697401
3 EX-5.1 a19-6607_1ex5d1.htm EX-5.1 38324
4 EX-23.1 a19-6607_1ex23d1.htm EX-23.1 4944
5 GRAPHIC g66071boi001.gif GRAPHIC 5644
6 GRAPHIC g66071kyi001.gif GRAPHIC 2263
7 GRAPHIC g66071bki001.gif GRAPHIC 5594
8 GRAPHIC g66071bii001.gif GRAPHIC 5013
  Complete submission text file 0001104659-19-015318.txt   1194246
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-230341 | Film No.: 19685851
SIC: 2834 Pharmaceutical Preparations